|
|
|
 | |
MedChem 2011 - Emerging Targets and Treatments:
Opportunities and Challenges for Drug Design |
| Scientific and Organising Committee |
| Members |
| Prof. K. AUGUSTYNS (University of Antwerp, Antwerp, Belgium) |
| Prof. W. DEHAEN (KULeuven, Heverlee, Belgium) |
| Dr E. DIFFERDING (Differding Consulting, Louvain-la-Neuve, Belgium) |
| Prof. P. HERDEWIJN (KULeuven, Leuven, Belgium) |
| Dr B. KENDA (UCB, Braine-l'Alleud, Belgium) |
| Prof. D. LAMBERT (UCL, Bruxelles, Belgium) |
| Prof. B. MAES (University of Antwerp, Antwerp, Belgium) |
| Prof. B. MASEREEL (UNamur, Namur, Belgium) |
| Prof. J. NEVE (ULB, Bruxelles, Belgium) |
| Prof. B. PIROTTE (ULg, Liège, Belgium) |
| Prof. J. QUETIN-LECLERCQ (CATHOLIC UNIVERSITY OF LOUVAIN (UCL), Brussels, Belgium) |
| Dr D. SURLERAUX (Idenix, Saint Gely du Fesc, France) |
| Dr P. TEN HOLTE (Johnson & Johnson PRD, Beerse, Belgium) |
| Prof. D. TOURWE (VUB, Brussels, Belgium) |
| Prof. S. VAN CALENBERGH (UGent, Ghent, Belgium) |
| Prof. J. VAN DER EYCKEN (UGent, Ghent, Belgium) |
| Dr G. VAN LOMMEN (Galapagos, Mechelen, Belgium) |
|
| <Previous page |
|
|
|
.jpg){kind=small}